NFKB1 and cancer: We found that the p65 subunit of NF-κB subunit was phosphorylated in mammospheres derived from HER2+ early cancer cells, and lapatinib, a HER2 and EGFR inhibitor, inhibited its phosphorylation (Fig. 6a, Supplementary Table 6 and Supplementary Fig. 7).